Waracharee Srifa

Employment

• Naresuan University Faculty of Medicine Lecturer
  2022 - Present
• T-Rex Bio, Inc. Scientist II
  2020 - 2022

Education

• Stanford University School of Medicine PhD
  2014 - 2020
• Bowdoin College BA (Double Majors)
  2010 - 2014

Projects & Funding

Projects & funding information is unavailable.

Publications (15)

• Correction of recessive dystrophic epidermolysis bullosa by homology-directed repair-mediated genome editing
  Jose Bonafont, Ángeles Mencía, Esteban Chacón-Solano +11 more
  Molecular Therapy 2021 DOI: 10.1016/j.ymthe.2021.02.019
  +Save
• Development of beta;-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease
  Annalisa Lattanzi, Joab Camarena, Premanjali Lahiri +20 more
  Science Translational Medicine 2021 DOI: 10.1126/scitranslmed.abf2444
  +Save
• Gene replacement of α-globin with β-globin restores hemoglobin balance in β-thalassemia-derived hematopoietic stem and progenitor cells
  M. Kyle Cromer, Joab Camarena, Renata M. Martin +20 more
  Nature Medicine 2021 DOI: 10.1038/s41591-021-01284-y
  +Save
• Metabolic engineering generates a transgene-free safety switch for cell therapy
  Volker Wiebking, James Oliver Patterson, Renata M. Martin +5 more
  Nature Biotechnology 2020 DOI: 10.1038/s41587-020-0580-6
  +Save
• Cas9-AAV6-engineered human mesenchymal stromal cells improved cutaneous wound healing in diabetic mice
  Waracharee Srifa, Nina Kosaric, Alvaro Amorin +6 more
  Nature Communications 2020 DOI: 10.1038/s41467-020-16065-3
  +Save
• Gene replacement of α-globin with β-globin restores hemoglobin balance in β-thalassemia-derived hematopoietic stem and progenitor cells
  bioRxiv 2020 DOI: 10.1101/2020.10.28.359315
  +Save
• Macrophage Subpopulation Dynamics Shift following Intravenous Infusion of Mesenchymal Stromal Cells
  Nina Kosaric, Waracharee Srifa, Clark Andrew Bonham +8 more
  Molecular Therapy 2020 DOI: 10.1016/j.ymthe.2020.05.022
  +Save
• Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells (Nature Communications, (2019), 10, 1, (1634), 10.1038/s41467-019-09614-y)
  Mara Pavel-Dinu, Volker Wiebking, Beruh T. Dejene +15 more
  Nature Communications 2019 DOI: 10.1038/s41467-019-10080-9
  +Save
• Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells (Nature Communications, (2019), 10, 1, (1634), 10.1038/s41467-019-09614-y)
  Mara Pavel-Dinu, Volker Wiebking, Beruh T. Dejene +15 more
  Nature Communications 2019 DOI: 10.1038/s41467-019-13620-5
  +Save
• Gene correction for SCID-X1 in long-term hematopoietic stem cells
  Mara Pavel-Dinu, Volker Wiebking, Beruh T. Dejene +15 more
  Nature Communications 2019 DOI: 10.1038/s41467-019-09614-y
  +Save
• Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease
  So Hyun Park, Ciaran M. Lee, Daniel P. Dever +9 more
  Nucleic Acids Research 2019 DOI: 10.1093/nar/gkz475
  +Save
• Exposure to the oral host niche yields rapid phenotypic and genotypic diversification in Candida albicans
  bioRxiv 2018 DOI: 10.1101/254201
  +Save
• Gene Correction for SCID-X1 in Long-Term Hematopoietic Stem Cells
  bioRxiv 2018 DOI: 10.1101/397463
  +Save
• Rapid phenotypic and genotypic diversification after exposure to the oral host niche in candida albicans
  Genetics 2018 DOI: 10.1534/genetics.118.301019
  +Save
• Precise correction of disease mutations in induced pluripotent stem cells derived from patients with limb girdle muscular dystrophy
  Molecular Therapy 2016 DOI: 10.1038/mt.2016.40
  +Save